Skip to main content
OpenTrials
Completed

NCT Number: NCT05126225

Buddhist Understanding and Reduction of Myanmar Experiences of HIV Stigma and Exclusion

This project aims to explore a multi-leveled conceptualization of the effects of HIV stigma on HIV care engagement in Myanmar by conducting a mixed-method study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Acquired Immunodeficiency Syndrome Behavior Blood-Borne Infections Communicable Diseases Genital Diseases HIV Infections Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Mindfulness RNA Virus Infections Retroviridae Infections Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Slow Virus Diseases Social Behavior Social Stigma Stigma, Social Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Myanmar Positive Group, Yangon, Myanmar, Burma

Loading trial locations.

About this study

This project is to explore how Myanmar People Living With HIV (PLWH) experience and manage HIV stigma as inspired by Buddhist teaching, and to adapt an evidence-based stigma-reduction intervention to tailor treatment for the unique needs of Myanmar People Living With HIV.

A stigma-reduction intervention will be adopted to the needs of Myanmar People Living With HIV with six focus groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • HIV-Positive
  • Care by Myanmar Positive Group/CMRU
  • Living in Myanmar/Thailand
  • can stay in the period of intervention

Exclusion criteria

  • Not HIV
  • Living outside of Myanmar/Thailand
  • Not care by MPG/CMRU
  • Cannot stay for the study period

Treatment and study plan

Stigma reduction

Behavioral

The intervention is modularized to have eight weekly sessions of 2-hour group discussions, led by a trained facilitator. The facilitator applies the principle of CBT and provides psychoeducation to promote the awareness and understanding of HIV stigma as well as training to help participants acquire alternative coping skills, such as relaxation techniques.

Primary outcomes

  1. Change in Stigma Score From Baseline to End of Intervention in Protocol Group

    Time frame: Baseline and 8 weeks

    Perceived Stigma Scale (PSS). Each item is measured using a 4-point Likert scale and the scale contains four factors: personalized stigma (18 items, subscore total 18-72), disclosure concerns (12 items, subscore total 12-48), negative self-image (9 items, subscore total 9-36), and concern with public attitudes about people with HIV (12 items, subscore total 12-48). Each factor is scored separately, with total score is computed by summing all 40 items, with a minimum total PSS score of 40 and a maximum possible score of 160. Raw PSS scores were transformed into Stigma scores 1-4. Higher scores reflect higher levels of perceived stigma.

Secondary outcomes

  1. Change in QOL Score From Baseline to End of Intervention in the Protocol Group

    Time frame: Baseline and 8 weeks

    Cognitive and Affective Mindfulness Scale-Revised (CAMS-R) is a 12-item questionnaire that was used as a proxy measure of QOL in the study. Total maximum score of CAMS-R is 48 and minimum score is 12. Raw CAMS-R scores were transformed into QOL scores 0-3. Higher scores reflect better QOL.

Sponsors and collaborators

Lead sponsor

University of California, Los Angeles

Other

Collaborators

  • Chiangmai Rajabhat University
  • Fogarty International Center of the National Institute of Health

Registry information

Acronym: BURMESE

Important dates

Study start
2020
Primary completion
2023
Study completion
2024
First posted
Nov 18, 2021
Registry last updated
Dec 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.